Recce Pharmaceuticals Ltd

ASX:RCE.AX

0.305 (AUD) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

2025 Q22024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q2
Operating Activities:
Net Income -7.735-10.2-7.462-3.855-9.223-6.003-4.984-3.321-10.192-2.985-1.332-1.724-1.065-0.63-1.044-1.693-1.333-0.884-3.956-0.265-0.185-0.136-0.136-0.146-0.146
Depreciation & Amortization 0.0860.1730.1930.1420.0750.0790.1080.2050.0910.10.10.0290.0270.0280.0260.0150.0110.010.0060.0050.0050000
Deferred Income Tax 00000-0.4780-0.6920-0.218000-0.1100.0400.0170-0.07600000
Stock Based Compensation 0.3840000.3250.25600.4864.7320.0220.033000.0710-0.0190.0320.0073.3150.09100.0060.00600
Change In Working Capital 000-0.91801.4190-0.13400.07500.03200.06900.06100.0400.0100000
Accounts Receivables 0000.09200.0630-0.2040-0.0050-0.01600.0390-0.0210-0.0240-0.01600000
Change In Inventory 0000000000000000000000000
Change In Accounts Payables 0000000000000000000000000
Other Working Capital 000-1.0101.35600.0700.0800.04800.02900.08200.06400.02600000
Other Non Cash Items 0.3413.5351.1381.505-0.8981.8120.3520.9894.9640.6940.0160.1550.025-0.068-0.1830.3850.043-0.2660.120.0270.0150.130.130.1460.146
Operating Cash Flow -6.924-6.491-6.517-2.491-10.196-4.27-4.74-2.538-5.318-2.391-1.416-1.599-1.014-0.531-1.202-1.251-1.246-1.092-0.515-0.131-0.1650.0060.00600
Investing Activities:
Investments In Property Plant And Equipment -0.018-0.036-0.106-0.034-0.004-0.031-0.009-0.069-0.007-0-0.006-0.006-0.084-0.009-0.169-0.2460-0.078-0-0.034-0.0010000
Acquisitions Net 0000000000000000000000000
Purchases Of Investments 0000000000000000000000000
Sales Maturities Of Investments 0000000000000000000000000
Other Investing Activites -0.390.034-0.034-0.3950.3950.298-0.2980.041-0.0410000000.026-0.02600.06000000
Investing Cash Flow -0.408-0.002-0.14-0.4290.390.267-0.307-0.028-0.048-0-0.006-0.006-0.084-0.009-0.169-0.22-0.026-0.0780.059-0.034-0.0010000
Financing Activities:
Debt Repayment 07.366-1.480000000-0.7370.2810-0.020.020000000000
Common Stock Issued 0-0.00210.5850.0290.0730.28700.00526.3330.5596.4211.6910000000000000
Common Stock Repurchased 00000000000000000-0.1510000000
Dividends Paid 0000000000000000000000000
Other Financing Activities 4.86-0.46402.6040-0.5280-0.2150-0.15000.4530.00300.25-0.007-0.2395.0050.5840.1050000
Financing Cash Flow 4.866.99.1052.6330.073-0.240-0.2126.3330.4095.6841.9730.4530.0831.4170.25-0.007-0.2395.0050.5840.1050000
Other Information:
Effect Of Forex Changes On Cash 000-1.56211.582-11.5820-20.8242.633-2.6820.403-0.4030.68-0.681.09-1.093.591-3.5910.452-0.4520.0940000
Net Change In Cash 1.9440.1992.447-0.287-9.733-4.244-5.047-2.72620.917-1.9834.2620.3680.035-1.1371.137-2.3122.312-5.0015.001-0.0330.0330.0110.01100
Cash At End Of Period 1.9444.2074.0091.5621.84911.58215.82620.87323.5992.6824.6650.4030.03501.13702.31205.00100.0330.0110.01100